Non-CIN | CIN | P-value | ||
---|---|---|---|---|
Subjects, n | 315 | 28 | – | |
Males, n (%) | 228 (72.4) | 19 (67.9) | 0.609 | |
Age, y | < 45 | 24 (7.6) | 1 (3.6) | 0.723 |
45–59 | 144 (45.7) | 14 (50) | ||
60–74 | 140 (44.5) | 13 (46.4) | ||
≥75 | 7 (2.2) | 0 (0.0) | ||
Weight, kg | 71.0 (65.0–80.0) | 70.0 (65.0–78.0) | 0.643 | |
Height, m | 1.7 (1.6–1.7) | 1.7 (1.6–1.7) | 0.571 | |
Smoking | 136 (43.2) | 10 (35.7) | 0.444 | |
Underlying diseases | Hypertension | 188 (59.7) | 19 (67.9) | 0.397 |
Diabetes mellitus | 79 (25.1) | 5 (17.9) | 0.394 | |
Hyperlipidemia | 144 (45.7) | 10 (35.7) | 0.308 | |
Medication history | ACEI or ARB | 138 (43.8) | 16 (57.1) | 0.174 |
Statins | 290 (92.1) | 24 (85.7) | 0.277 | |
AMI | 103 (32.7) | 16 (57.1) | 0.009 | |
Before PCI | Multi-vessel lesions | 85 (27.0) | 9 (32.1) | 0.558 |
Heart failure | 66 (21.0) | 9 (32.1) | 0.170 | |
Ejection fraction | 61.8 (60.6–63.1) | 61.3 (57.7–63.6) | 0.303 | |
LV, mm | 47.0 (45.0–50.0) | 49.5 (46.3–52.0) | 0.014 | |
Types of CM | Iso-osmotic | 11 (3.5) | 4 (14.3) | 0.026 |
Low-osmotic | 304 (96.5) | 24 (85.7) | ||
Contrast dose, mL | 100 (100–160) | 100 (100–160) | 0.327 | |
Hemoglobin, g/L | 138.2 ± 12.7 | 139.0 ± 11.4 | 0.748 | |
SCr, μmol/L | 69.3 (60.1–77.4) | 60.4 (51.5–64.7) | 0.000 | |
BUN, mmol/L | 5.1 (4.3–6.1) | 5.1 (3.9–5.7) | 0.549 | |
Cystatin C, mg/L | 1.0 (0.9–1.1) | 1.0 (0.9–1.1) | 0.981 | |
FBG, mmol/L | 4.9 (4.4–5.8) | 5.6 (4.8–6.7) | 0.016 | |
TC, mmol/L | 4.2 (3.6–4.9) | 4.5 (3.9–4.8) | 0.328 | |
Homocysteine, μmol/L | 16.2 (13.3–22.0) | 17.2 (13.1–22.8) | 0.660 | |
Albumin, g/L | 41.3 ± 3.5 | 40.5 ± 3.8 | 0.259 | |
Contrast media, mL | 100 (100–160) | 160 (100–160) | 0.327 |